文献速递血液透析通路

美国印第安人自体血管通路的建立

Autogenous Vascular Access in American Indians.
PubMed 文献 · Ann Vasc Surg · 2021-12-22

回顾性分析10年间235例连续新发美国印第安人血液透析血管通路患者,全部构建自体动静脉内瘘。12个月和24个月一期通畅率分别为62%和46%,累积通畅率分别为96%和94%。尽管糖尿病和肥胖患病率较高,仍可建立安全且功能良好的动静脉内瘘。

要点

  • 235例美国印第安人全部构建自体动静脉内瘘,糖尿病占85%,肥胖占27%。
  • 12个月和24个月一期通畅率分别为62%和46%,累积通畅率分别为96%和94%。
  • 女性、既往通路手术与较低一期及累积通畅率相关,肥胖与较低累积通畅率相关。

核心结论

  • 尽管糖尿病和肥胖等血管通路危险因素患病率较高,仍可为美国印第安人建立安全且功能良好的动静脉内瘘。

研究设计与样本

  • 回顾性分析血管通路数据库中10年期间连续新发美国印第安人血液透析血管通路患者,共235例,全部构建自体通路。
  • 每例患者均由手术医生进行超声血管定位,并结合病史和体格检查。

主要发现

  • 中位年龄56岁(范围15-89岁),糖尿病占85%,女性占42%,肥胖占27%,37%有既往血管通路手术史。
  • 12个月和24个月一期通畅率分别为62%和46%,累积通畅率分别为96%和94%。
  • 女性与较低一期通畅率相关(P=0.002)、与较低累积通畅率相关(P=0.01);既往通路手术与较低一期通畅率相关(P=0.02)、与较低累积通畅率相关(P=0.04)。
  • 肥胖与较低累积通路通畅率相关(P=0.02)。
  • 74%的通路手术使用桡动脉或尺动脉作为动静脉内瘘流入道;远端桡动脉流入道动静脉内瘘与较长患者生存相关(P=0.01),近端桡动脉流入道者生存较肱动脉动静脉内瘘者长;既往通路手术与较短患者生存相关(P=0.04)。

关键数值与推荐

  • 初始穿刺目标为通路建立后4-6周;穿刺最小动静脉内瘘流量为500 mL/min,流出静脉直径6 mm。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: American Indians (AI) or Alaska Natives, or in combination with another race, comprised 6.8 million individuals in 2010 and the population is expected to exceed 10 million in the current census. Diabetes is more common in AIs than in other races in the United States and is responsible for 69% of new onset end stage renal disease in AI patients. The incidence of obesity is also higher among AIs. As both diabetes and obesity make creating a successful autogenous vascular access more challenging, we reviewed our experience creating arteriovenous fistulas in AI patients. METHODS: Our vascular access database was reviewed for consecutive new AI patients undergoing creation of a hemodialysis vascular access during a 10-year period. Each patient underwent ultrasound vessel mapping by the operating surgeon in addition to history and physical examination. The goal for initial cannulation was 4-6 weeks after access creation. Minimal AVF flow volume for cannulation was 500 mL/min with an outflow vein diameter of 6 mm. RESULTS: 235 consecutive new AI patients were identified. All patients had an autogenous access constructed. The median age was 56 years (range, 15-89 years). Diabetes was present in 85% and 42% were female. Obesity was noted in 27% of the patients and 37% had previous vascular access operations. Primary patency at 12 and 24 months was 62% and 46%, respectively. Cumulative patency at 12 and 24 months was 96% and 94%, respectively. Female gender and previous access operations were associated with lower primary (P = 0.002 and 0.02, respectively) and cumulative patency (P = 0.01 and 0.04, respectively). Obesity was associated with lower cumulative access patency (P = 0.02). Overall, 74% of the access operations used the radial or ulnar artery for AVF inflow. Distal radial artery inflow AVFs were associated with longer patient survival (P = 0.01) and individuals with proximal radial inflow had longer survival when compared to brachial artery AVFs. Previous access operations were associated with shorter patient survival (P = 0.04). CONCLUSIONS: Safe and functional arteriovenous fistulas can be created for American Indians despite a higher prevalence of vascular access risk factors such as diabetes and obesity.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kempe K, Nelson PR, Mushtaq N, et al. Autogenous Vascular Access in American Indians. Ann Vasc Surg. 2021. PMID: 34954040. doi:10.1016/j.avsg.2021.11.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。